We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.
11
7
0
2
Hashtag
#JCOOA
Advertisement · 728 × 90
Great news for #cancerresearch! A new ASCO/Friends of Cancer Research study in #JCOOA shows decentralized clinical trial elements are safe to adopt without hurting data quality or increasing patient risk.
Read more: shorturl.at/V7ZsJ
7
4
0
0
‼️ #ASCO25 #JCOOA simultaneous publication by O'Neill et al:
Implementation of a Medication Reconciliation Televisit Model in Phase I Oncology Clinical Trials. Read the full article: brnw.ch/21wT6uo @pamelakunzmd.bsky.social
5
3
0
0
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here:
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
0
1
1
0
Patterns of Homologous Repair Deficiency and BRCA1/2 Testing of Ovarian and Breast Cancers: A Real-World Study of Patients in Community Health Settings in the United States ascopubs.org/doi/10.1200/... #JCOOA #OpenAccess
1
0
0
0
“In patients with mRCC, Medicare was associated with significantly better survival outcomes compared with Medicaid/no insurance and having secondary insurance was associated with better PFS compared with primary insurance alone.” ascopubs.org/doi/10.1200/... #JCOOA
4
1
0
0
#JCOOA: Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid ascopubs.org/doi/10.1200/... #OpenAccess
3
1
0
0
"Our analysis demonstrated OS benefit of the NAC approach in T4 colon adenocarcinoma but not in T3. This study highlights the importance of evaluating the survival benefit of NAC separately for T3 and T4 colon adenocarcinoma in future studies." ascopubs.org/doi/10.1200/... #JCOOA #OpenAccess
1
1
0
0
New from #JCOOA: "Oncologists ... are experiencing higher rates of burnout compared with a decade ago. System-based interventions ... are necessary to maintaining an adequate workforce to provide care for current and future patients..." ascopubs.org/doi/10.1200/...
#JCOOA #JCOJournals #OpenAccess
4
1
0
0
Female med oncs receive significantly lower general payments than male med oncs: Sex-Based Bias in Industry Payments to Medical Oncologists ascopubs.org/doi/10.1200/...
#JCOOA #JCOJournals #OpenAccess
3
2
0
0
New from #JCOOA: Risk Stratification Using Tree-Based Models for Recurrence-Free Survival in Breast Cancer ascopubs.org/doi/10.1200/...
#JCOOA #JCOJournals #OpenAccess #BreastCancer #oncsky
1
0
0
0
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors ascopubs.org/doi/10.1200/...
#JCOOA #JCOJournals #oncsky
2
0
0
0
New from #JCOOA: Toward Functional Biomarkers of Response to Neoadjuvant Oncolytic Virus in Stage II Melanoma
ascopubs.org/doi/10.1200/...
#openaccess, #JCOJournals, #melanoma, #oncsky, @pamelakunzmd.bsky.social @ascocancer.bsky.social
1
0
0
0
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial— new today from #JCOOA #oncsky #JCOOncologyAdvances #JCOJournals #gynonc
ascopubs.org/doi/10.1200/...
3
1
0
0
New from #JCOOA Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non–Small Cell Lung Cancer: A SEER-Medicare Analysis #oncsky #openaccess #JCOJournals @pamelakunzmd.BlueSky.social
ascopubs.org/doi/10.1200/...
4
1
0
0
New! Impact of Bone Metastasis in Stage IV Non–Small Cell Lung Cancer Treated With Durvalumab and Tremelimumab With or Without Chemotherapy: A Retrospective Analysis of the CCTG BR.34 Trial #JCOOA #openaccess #oncsky #medsky ascopubs.org/doi/10.1200/...
1
0
0
0